Analytics-driven Contract Development and Manufacturing Organization (CDMO) specialized in Cell Therapy, Cell-Easy offers customized process development, GMP manufacturing and analytical services for immune cells (engineered CAR-T, NK cells and non-engineered cells) and adult stem cells (MSCs, iPSCs and Exosome) in Immuno-oncology and Regenerative Medicine fields.
Always keeping in mind delays and flexibility to perfectly fit with client’s expectations.
Cell-Easy facilities comprise 350 sqm of qualified controlled environment suites optimized to develop Manufacturing and Analytical Process, proceed to environmental and material Quality Control and execute cGMP Manufacturing, Fill&Finish, long-term Storage of ATMPs compliant with all the requirements of Regulatory Standards and cGMP guidelines.
- 3 cGMP Grade B compliant cleanroom areas with aseptic Isolators (Grade A)
- Dedicated room for Aseptic Filling, including semi-automatic equipment
- Dedicated rooms for Support and Storage
- Pharmaceutical-grade CO2, compressed air, and LN2 network supplies
- Environmental monitoring: particulates and viable counts
- Temperature, humidity and pressure monitoring
- cGMP storage capacity at room temperature, refrigerated, ultra-low freezing and cryopreservation temperatures
We like to think that our Services contribute to the development of the next generation of personalized therapies and are committed to bring the world of Cell&Gene therapy more accessible than we found it !
We aim at developing close partnership with our customers to deliver world-class CDMO Services, democratizing and securing Drug Development program through a pioneering ATMP analytics approach.
The Cell-Easy Management team and all collaborators have a strong expertise in the Development and Manufacturing of innovative cell-based therapies.
Over 20 years of experience in biotech entrepreneurship, he started at the Evry Genopole, France’s leading biotech cluster. Also founder of Physiogenex and Human cell design, start-up companies focused on stem cells and translational medicine.
PharmD and holder of an MBA, Alexis has over 15 years of experience in the pharmaceutical space. Lately, he co-founded and scaled up two Healthtech companies.
Expert in Bioproduction he has an outstanding track record of achievements both in the academic field and entrepreneurship (co-founder of Bio-Europe, Biotrade, Genibio 1998, and founder of Toulouse White Biotechnology).
Professeur at Toulouse III University, ex-Director of STROMAlab Institute and now co-leader of the RESTORE Got-IT team and co-manager of the EcellFrance QC facility, he co-discovered and patented in 2004 the angiogenic properties of adipose derived stem cells (ASC)
PhD in Immunology and Bacteriology, he worked at CNRS before moving into sales and business at Miltenyi Biotec for 13 years where he has held various positions as sales specialist in cell therapy, account manager and regional sales manager.
He acquired management and scientific skills (USP, DSP) during his past experiences in various pharmaceutical scales: in operational management functions within UCB, and in transversal & technical management functions within Vivalis and Transgene companies.
Quality Control Manager
Master degree in Microbiology, she has acquired over 15 years of experience at Sanofi, Ecole Nationale Vétérinaire de Toulouse, Servier and Nutrition&Santé SAS. She manages various analytical techniques in R&D and QC activities.
Quality Assurance DIRECTOR
Pharmacist and PhD in Oncology (Acute Leukemia), she worked for 10 years as Quality and Regulatory manager in various medical segments : experimental drugs, pharmaceutical raw material and medical devices.
Tel : +33 534 276 550
Address : Cell-Easy SAS, 4 bis avenue Hubert Curien, 31100 Toulouse, France
Mail : email@example.com